Maged Shenouda Insider Profile

4 Followers
Maged Shenouda, CFO at Relmada Therapeutics, holds 88.33K shares in Relmada Therapeutics (Ticker: RLMD), holds 62.50K shares in Entero Therapeutics (Ticker: ENTO). Most recently, Maged Shenouda Bought ― shares of Relmada Therapeutics on Sep 11, 2024 for an estimated value of 149.70K.
tipranks
Maged Shenouda

Maged Shenouda
Relmada Therapeutics (RLMD)
CFO

Ranked #51,485 out of 99,218 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

-1.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$338K
86.81%
13.19%
A breakdown of Maged Shenouda's holdings

Insider Roles

Relmada Therapeutics
(RLMD)
CFO
Entero Therapeutics
(ENTO)
CFO, Director
Roles that Maged Shenouda holds in companies

Most Profitable Insider Trade

Stock:
Relmada Therapeutics
(RLMD)
Rating:Informative Buy
Date:Sep 11, 2024 - Today
Return:+15.50%
The most profitable trade made by Maged Shenouda

Maged Shenouda's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Relmada Therapeutics
Sep 11, 2024
CFO
Informative Buy
149.70K
$293.27K
Entero Therapeutics
Jan 02, 2019
CFO, Director
Informative Buy
26.20K
$44.56K
List of latest transactions for each holding click on a transaction to see Maged Shenouda's performance on stock

Maged Shenouda insider profile FAQ

What is the percentage of profitable transactions made by Maged Shenouda?
The percentage of profitable transactions made by Maged Shenouda is 50%.
    What is the average return per transaction made by Maged Shenouda?
    The average return per transaction made by Maged Shenouda is -1.40%.
      What stocks does Maged Shenouda hold?
      Maged Shenouda holds: RLMD, ENTO stocks.
        What was Maged Shenouda’s latest transaction?
        Maged Shenouda latest transaction was an Informative Buy of $149.70K.
          What was Maged Shenouda's most profitable transaction?
          Maged Shenouda’s most profitable transaction was an Informative Buy of RLMD stock on September 11, 2024. The return on the trade was 15.50%.
            What is Maged Shenouda's role in Relmada Therapeutics?
            Maged Shenouda's role in Relmada Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.